Current Opinion in Virology

(The H4-Index of Current Opinion in Virology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
Structure of SARS-CoV-2 spike protein135
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19123
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection102
Recent advances in antiviral drug development towards dengue virus76
Future considerations for the mRNA-lipid nanoparticle vaccine platform64
Current challenges to virus discovery by meta-transcriptomics62
Zoonotic disease and virome diversity in bats59
Global overview and major challenges of host prediction methods for uncultivated phages57
Structure and function of SARS-CoV-2 polymerase54
Animal models for SARS-CoV-254
Coronavirus entry: how we arrived at SARS-CoV-253
The virome of vector mosquitoes53
Dengue vaccine development by the year 2020: challenges and prospects50
A structural view of the SARS-CoV-2 virus and its assembly50
A new generation of vaccines based on alphavirus self-amplifying RNA49
The healthy human virome: from virus–host symbiosis to disease48
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing46
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus45
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses43
Engineering therapeutic phages for enhanced antibacterial efficacy42
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi41
Viral Z-RNA triggers ZBP1-dependent cell death40
COVID-19, the first pandemic in the post-genomic era39
Structure, function and assembly of the long, flexible tail of siphophages39
European regulatory aspects of phage therapy: magistral phage preparations37
Host cell-intrinsic innate immune recognition of SARS-CoV-237
Influenza D virus35
Perspective on taxonomic classification of uncultivated viruses34
Anti-viral protective capacity of tissue resident memory T cells34
Dengue mouse models for evaluating pathogenesis and countermeasures34
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?34
Entry of influenza A virus into host cells — recent progress and remaining challenges34
Risk factors and biomarkers of severe dengue33